ROS1 and central nervous system cancer: However, methylation profiling classified the tumor as an infantile hemispheric glioma.37 This tumor type is characterized by targetable kinase fusions and a better outcome than glioblastoma.38 RNA-seq identified a ZCCHC8-ROS1 fusion (Fig 5B).